Case Studies: Breast Cancer
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
HER2+ Early-Stage Breast Cancer with Ruth O'Regan, MD
ER+/HER2-Breast Cancer with Adam Brufsky, MD, PhD and Kimberly Blackwell, MD
Triple Negative Breast Cancer with Andrew Seidman, MD and Joyce O'Shaughnessy, MD
Triple-Negative Breast Cancer
HER2-Negative Metastatic Breast Cancer
Safety and Efficacy of Combination Targeted Therapy and Radiotherapy
How to Refine Treatment Choice in Follicular Lymphoma
Immune Checkpoint Approaches in AML and MDS: A Next Frontier?
>> View Peer-Reviewed Articles
CRISPR Creates More Potent CAR T Cells
Avelumab Approved by FDA for Merkel Cell Carcinoma
EMA Recommends Nivolumab for Approval in Head and Neck Cancer
Levothyroxine Linked to Heart Risks in Patients With Thyroid Cancer
Follow Us on Social Media
SPECIAL REPORTS >
CASE STUDIES >
INTERNAL RESOURCES >
MJH Associates >
Hepatitis C CureToday
Specialty Pharmacy Times
Terms & Conditions
Copyright TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.